


Consultant
MD, GDipDC (Australia), FRCP (Edinburgh)
Type 2 Diabetes Mellitus – Diagnosis, Management and Advanced Pharmacotherapy
Insulin Pump Therapy and Continuous Glucose Monitoring (CGM)
Gestational Diabetes Mellitus and Diabetic Complications
Diabetic Neuropathy, Retinopathy, Nephropathy and Foot Care
Metabolic Syndrome, Obesity and Dyslipidemia Management
Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Liver Disease
Prediabetes, Gut Microbiota and Lifestyle Interventions
General Internal Medicine – Acute and Chronic Disease Management
Endocrinology and Thyroid Disorders
Clinical Research, Drug Trials and Evidence-Based Medicine
Intestinal Miyasis – Infectious Diseases in Clinical Practice, May 2009
Insulin Resistance and ALT Levels in First Degree Relatives of Patients with Type 2 Diabetes Mellitus – Dia & Met Syndrome: Clinical Research and Reviews, 2011
Clinical Experience with Insulin Detemir, Biphasic Insulin Aspart and Insulin Aspart in Type 2 Diabetes – Results from the Chennai Cohort of the ACHIEVE Study – Indian Journal of Endocrinology and Metabolism, 2013
Study on Glycaemic Control by Canagliflozin and Its Effects on Insulin Resistance and Plasma Ketone in Type 2 Diabetes Mellitus – Journal of Diabetology, 2019
Human Tongue Thermography as a Prognostic Tool for Pre-Screening Type 2 Diabetes Mellitus – Evidence-Based Complementary and Alternative Medicine, January 2020
Clinical Profile and Outcomes of Critically Ill COVID-19 Patients Admitted in a Tertiary Care Hospital – Ann Trop Med & Public Health, November 2020
A Randomized Open-Label Trial of the Efficacy of Ranolazine in Patients with Type 2 Diabetic Dyslipidemia – Obesity Medicine, 2021
Pharmacist-Led Intervention Towards Management of Type 2 Diabetes Mellitus – Diabetes Metab Syndr, 2021
Impact of Telomere Attrition on Diabetes Mellitus and Its Complications – Diabetes Epidemiology and Management, 2023
Metabolic Consequences of Alterations in Gut Microbiota Induced by AntidiabeticMedications – Diabetes Epidemiology and Management, 2023
Overview of Therapeutic Options of Obesity Management in India – IDEA 2023 Congress Update – Expert Review of Clinical Pharmacology, 2024
Artificial Sweeteners and Their Implications in Diabetes – Frontiers in Nutrition, 2024
Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus – Life, 2024
Development of a Near Infrared Region Based Non-Invasive Therapy Device for Diabetic Peripheral Neuropathy – Scientific Reports, 2024
Multistrain Probiotics and Telomere Length in Type 2 Diabetes – A 24-Week Randomized Controlled Trial – Life, 2025
The Role of Gut Microbiota and Bacterial Translocation in Type 2 Diabetes Mellitus – Physiology & Behavior, 2025
Association of Serum Hepcidin Levels and Cardiovascular Disease Among Patients with End Stage Kidney Failure – Journal of Clinical and Diagnostic Research, 2026
A Non-Invasive System for Monitoring Glucose Levels in a User and a Method Thereof – Application No. 202441002914A
Guide – Lifestyle Intervention in Prediabetic Population at Community Level
Guide – Comparative Effectiveness of Saroglitazar and Ranolazine in NAFLD in Patients with Diabetic Dyslipidemia (Completed RCT)
Co-Guide – Non-Invasive Approach for Type 2 Diabetes Using Thermal Imaging
Current PhD Guide – Gut Microbiota and Non-Nutritive Sweeteners; Role of Probiotics in Diabetic Patients
Annals of Internal Medicine (2008–2012)
Journal of Diabetology (2018 onwards)